An inhibitor of the mitochondrial respiratory chain exerts synergistic anti‐tumour effects when combined with alkylating agents

苯达莫司汀 氧化磷酸化 癌症研究 药理学 癌细胞 化学 糖酵解 谷氨酰胺分解 线粒体呼吸链 呼吸链 瓦博格效应 线粒体 抗霉素A 生物化学 癌症 柠檬酸循环 细胞培养 细胞周期 淋巴瘤 联合疗法 生物 作用机理 新陈代谢 细胞 细胞外 代谢途径
作者
Emiri O. Takaki,Yuya Hidoh,Yutaka Obuchi,Yoko Nagai,Shingo Nishikori,Yuki Kuniyoshi,Yasuhiro Sawai,Naoto Ohi
出处
期刊:British Journal of Pharmacology [Wiley]
标识
DOI:10.1111/bph.70719
摘要

BACKGROUND AND PURPOSE: Cancer cells exhibit the Warburg effect, but oxidative phosphorylation (OXPHOS) is also important for cancer cell proliferation. Metabolic reprogramming from glycolysis to OXPHOS is one mechanism of resistance to anti-tumour drugs. Here, we have synthesized and characterized OPB-111077, a novel, first-in-class orally available small-molecule compound, and investigated its anti-tumour activity and therapeutic potential in combination with alkylating agents. EXPERIMENTAL APPROACH: Inhibition of mitochondrial function by OPB-111077 were assessed by measuring the oxygen consumption rate, ATP production and Complex I enzymatic activity. anti-tumour effects were evaluated in human haematological and solid tumour cell lines and in cell line-derived xenograft and lymphoma patient-derived xenograft models. Mechanistic studies included CRISPR screening, metabolomic analyses, and measurements of the oxygen consumption and extracellular acidification rates. Effects of OPB-111077 combined with alkylating agents were also assessed in mice. KEY RESULTS: OPB-111077 inhibited mitochondrial respiratory chain Complex I, suppressed OXPHOS, and exerted anti-tumour effects in several models. OPB-111077 demonstrated synergism with the alkylating agent bendamustine, with simultaneous inhibition of both OXPHOS and glycolysis. Bendamustine reprogrammed cancer cells into an OXPHOS-dominant state, thereby enhancing the efficacy of OPB-111077. CONCLUSION AND IMPLICATIONS: Based on these findings, we propose a novel anticancer therapeutic strategy of combining OXPHOS inhibitors with alkylating agents. OPB-111077 has demonstrated potential in combination therapy and was recently evaluated with bendamustine and rituximab in a Phase 1 clinical trial for patients with relapsed/refractory diffuse large B-cell lymphoma (NCT04049825).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
采夏发布了新的文献求助10
刚刚
bkagyin的应助被lhj采纳,获得10
刚刚
研友_VZG7GZ的应助被momo采纳,获得10
1秒前
1秒前
水水的发布了新的文献求助10
1秒前
2秒前
3秒前
3秒前
852的应助被小明同学采纳,获得10
3秒前
3秒前
CC完成签到,获得积分10
4秒前
初(*^▽^*)心的应助被李zihua采纳,获得10
4秒前
5秒前
5秒前
稀饭完成签到 ,获得积分10
7秒前
7秒前
cst发布了新的文献求助10
7秒前
8秒前
春亦晚完成签到,获得积分10
8秒前
8秒前
8秒前
怡然的海秋完成签到 ,获得积分10
8秒前
9秒前
EarendilK发布了新的文献求助10
9秒前
9秒前
9秒前
9秒前
王硕磊完成签到,获得积分10
10秒前
我想静静发布了新的文献求助10
10秒前
10秒前
顶冠纹关注了科研通微信公众号
10秒前
10秒前
10秒前
所所的应助被cai采纳,获得10
10秒前
万能图书馆的应助被采夏采纳,获得10
10秒前
DURIAN发布了新的文献求助10
11秒前
11秒前
猪哥发布了新的文献求助10
11秒前
李健的粉丝团团长的应助被AAA采纳,获得10
12秒前
复杂的花瓣的应助被maodoudou采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163790
求助须知:如何正确求助?哪些是违规求助? 9557902
关于积分的说明 21742487
捐赠科研通 7754436
什么是DOI,文献DOI怎么找? 3428350
关于科研通互助平台的介绍 2553017
邀请新用户注册赠送积分活动 2472963